201. Feasibility and safety of laser balloon pulmonary vein isolation in patients with prior left atrial appendage occlusion device implantation
- Author
-
Charl Khalil, Sharath C. Vipparthy, David Kenigsberg, Venkatesh Ravi, Sorin Lazar, Rami Doukky, Grzegorz Pietrasik, Jeremiah Wasserlauf, Timothy Larsen, Parikshit S. Sharma, and Henry D. Huang
- Subjects
Male ,Lasers ,Middle Aged ,Treatment Outcome ,Pulmonary Veins ,Physiology (medical) ,Atrial Fibrillation ,Humans ,Feasibility Studies ,Female ,Atrial Appendage ,Cardiology and Cardiovascular Medicine ,Aged ,Retrospective Studies - Abstract
With the increasing adoption of left atrial appendage occlusion (LAAO) procedures and the eligibility of patients for pulmonary vein isolation (PVI) post device placement, we examined the feasibility and safety of laser balloon (LB) for PVI in patients with prior LAAO.We retrospectively examined consecutive patients with paroxysmal or persistent, drug-resistant atrial fibrillation (AF) who underwent LB PVI, after Watchman FLX device implantation at Rush University Medical Center between January 2020 and December 2021.Seven patients (four persistent and three paroxysmal) with a mean age of 64 ± 11 years, predominantly male sex (86%), were included in the study. Two (29%) patients had prior cryoablation PVI with recurrence of AF. The mean CHALB PVI was safe and effective with 100% acute isolation of left-sided veins in patients with prior LAAO device.
- Published
- 2022